Laboratory research material only. Not for human or animal consumption.
Home/Shop/Retatrutide 10mg
Retatrutide 10mg research peptide vial · Polaris Research

Weight & Metabolism · 10mg

Retatrutide 10mg

CAS 2381089-83-2

$149
Low stock, selling fast
1
#2 in monthly peptide rankings
Free Express Delivery, No Minimum
Quality Certificate Included
Card, PayPal or PayID
Sealed Under Argon
Reserved for 24h Once Ordered

Retatrutide, also written as Reta or the Reta peptide and sometimes mistyped Retatrude, R3ta peptide, or Reda peptide, is a triple-agonist research peptide studied across three of the most discussed metabolic targets in the current literature: the GLP-1, GIP, and glucagon receptor pathways. Where earlier compounds engaged one or two of these receptors, retatrutide is studied for reaching all three at once, which is why it sits at the centre of appetite-signalling and metabolic-balance research. The 10mg vial is the standard entry format and divides cleanly into the reference aliquots most laboratories work with.In preclinical and in-vitro settings, retatrutide is investigated for how simultaneous engagement of the three receptors influences appetite signalling, glucose-handling models, and body-composition pathways. The interest is in the interaction between receptors rather than any single one, and the metabolic literature approaches these triple-agonist compounds as tools for studying signalling rather than as finished products.Retatrutide is frequently studied alongside single- and dual-agonist peptides for comparison, and our library guide on retatrutide versus tirzepatide walks through how the receptor profiles differ. Researchers running longer investigation blocks often step up to the Retatrutide 20mg vial for better per-milligram value, while the 10mg format suits shorter protocols or a first reference batch. Both vials carry the same CAS reference, 2381089-83-2.Every 10mg vial of retatrutide ships lyophilised (freeze-dried) with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number printed on the label. Reconstitute with bacteriostatic water on arrival: add it slowly down the inside wall of the vial, swirl gently to dissolve, and never shake. Store the unopened vial refrigerated at 2 to 8°C; once reconstituted, keep the solution refrigerated and avoid repeated freeze-thaw cycles.Buying retatrutide in Australia is straightforward: every vial is dispatched from within Australia with free Australia Post Express shipping to every state and territory, no minimum spend, and tracking on every parcel. There are no customs delays and no international freight uncertainty. Checkout accepts card, PayPal, or PayID, each order is sealed under argon, and a 24-hour payment reservation holds your stock from the moment you order. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.

Formal Name
Retatrutide
CAS Number
2381089-83-2
Purity
99.6% · batch-tested
Description
Triple-agonist research peptide targeting GLP-1, GIP and glucagon receptor pathways, positioned for metabolic and appetite-signalling research.
Research Focus
Metabolic research, appetite signalling, body-composition pathways and glucose-handling models.
Suggested Use
Reference plan: 2 mg aliquots on a once-weekly research cadence. Begin conservatively and only escalate if the protocol has a qualified reason.
Doses per Vial
5 x 2 mg reference aliquots.
Concentration
2 mg per reference aliquot from a 10 mg vial.
Notes
Investigational compound; strongest human data are obesity trials, not general wellness use.
Monthly Ranking

#2 most popular research peptide

View ranking

Retatrutide carries 175 indexed publications, 34 registered trials, 6 with Australian sites, 39,578 monthly readers on Wikipedia. Research activity sits at 73 papers in the past twelve months against 57 the year before.

Why It's Searched

High-intent searches for GLP-1, GIP, and glucagon-pathway research peptides.

Evidence Standing

175 papers, 73 this year · 34 trials, 6 in Australia · 39,578 readers (-29%) · S tier

retatrutide australiaretatrutide peptideretatrutide 10mgretatrutide 20mg
Updated 2 August 2026

Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.

Independent Research
Evidence Overview on reptides.co

Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.

Pairs Well With

Complete your order

Related Reading

From the library

Other Quantities

Other formats & sizes

Also Searched As·Retatrutide is also searched as Reta peptide, Reta, R3ta peptide, Reda peptide, Ratatouille peptide, Retatrude, Retatrutide peptide, Skinny jab, Triple G peptide.

Research File

What has been published on Retatrutide

Accelerating

Retatrutide appears in 175 indexed publications going back to 2022, including 73 in the past twelve months. 34 registered trials appear on ClinicalTrials.gov, 6 with Australian sites.

175
Indexed publications
73
Past 12 months
34 (6 AU)
Registered trials
39,578
Monthly readers, down 29%
20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20150
20160
20170
20180
20190
20200
20210
20222
202316
202441
202558
202658
Read the full Retatrutide research fileCounts from Europe PMC and ClinicalTrials.gov, refreshed weekly. Reported as a record of what exists, not as evidence of any effect.